文献速递乳腺癌放疗放疗物理与技术

持续气道正压用于乳腺癌放疗:前瞻性临床试验方案

Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-06-03

该前瞻性试验纳入需保乳术后放疗的乳腺癌患者,左侧者含或不含区域淋巴结照射、右侧者需区域淋巴结照射,比较CPAP与非CPAP计划。若CPAP使平均心脏或对侧乳腺剂量降低≥0.5 Gy、或平均肺剂量降低≥1 Gy,则采用CPAP治疗,并评估舒适度、照射时间、准确性与可重复性。

要点

  • CPAP可能降低左侧乳腺癌放疗的心脏和对侧乳腺剂量。
  • 试验同时纳入左侧与右侧乳腺癌患者评估CPAP。
  • 以平均心脏或对侧乳腺剂量降低≥0.5 Gy或平均肺剂量降低≥1 Gy作为采用CPAP的阈值。

核心结论

  • 该试验旨在验证CPAP在更大乳腺癌队列中降低危及器官剂量的作用并评估可行性。
  • 最终目标是为临床实施提供患者选择模型和指南。

研究设计与样本

  • 前瞻性临床试验,纳入需保乳手术和放疗的乳腺癌患者,包括左侧含或不含区域淋巴结照射者及右侧需区域淋巴结照射者。
  • 每例患者额外进行CT模拟:右侧采用自由呼吸,左侧采用深吸气屏气;左侧无法完成深吸气屏气或≥70岁者在自由呼吸下评估。
  • 比较有无CPAP的两套放疗计划,样本量计算显示需53例患者以检测平均心脏剂量≥0.5 Gy的降低。
  • 试验注册于Clinicaltrials.gov(NCT07373782)。

关键数值与推荐

  • 若CPAP使平均心脏或对侧乳腺剂量降低≥0.5 Gy,或平均肺剂量降低≥1 Gy,则采用CPAP治疗。
  • 通过问卷调查评估患者舒适度。

临床怎么用

  • 对符合条件的乳腺癌放疗患者可考虑使用CPAP以降低心脏、对侧乳腺和肺剂量。
  • 根据预设剂量降低阈值决定是否采用CPAP治疗。

局限性

  • 本文为试验方案,尚未报告实际结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiotherapy (RT) improves survival and local control after breast-conserving surgery (BCS) for breast cancer (BC) but can also cause toxicity. Preliminary studies suggest that continuous positive airway pressure (CPAP) reduces organ-at-risk (OAR) doses in left-sided BC RT. This prospective trial evaluates whether CPAP reduces OAR doses in a larger patient cohort, including both left and right-sided cases, and identifies which patients benefit most. Furthermore, this study investigates the feasibility of CPAP in BC RT, by evaluating patient comfort, radiation time, accuracy and reproducibility. METHODS: BC patients requiring BCS and RT are prospectively enrolled -left-sided cases with or without regional nodal irradiation (RNI), or right-sided cases requiring RNI. Each patient undergoes an additional CT simulation with CPAP-free breathing (FB) for right-sided cases and deep inspiration breath hold (DIBH) for left-sided cases. Left-sided patients unable to perform DIBH or ≥ 70 years old are evaluated in FB. Two RT plans (with and without CPAP) are compared. If CPAP reduces mean heart or contralateral breast dose by ≥0.5 Gy, or mean lung dose by ≥1 Gy, treatment is delivered with CPAP. Patient comfort is assessed through surveys. Sample size calculations indicated that 53 patients are required to detect a ≥0.5 Gy reduction in mean heart dose. DISCUSSION: This is the first large, prospective study to evaluate CPAP in both left- and right-sided BC patients, aiming to demonstrate OAR dose reductions and assess feasibility. The final aim is to provide patient-selection models and guidelines for clinical implementation. TRIAL REGISTRATION: The study is registered on Clinicaltrials.gov (NCT07373782).

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Van der Vorst A, Verhoeven J, Baten A, et al. Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial. Clin Transl Radiat Oncol. 2026. PMID: 42305413. doi:10.1016/j.ctro.2026.101209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。